Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02228382
Title	Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors
Recruitment	Terminated
Gender	both
Phase	FDA approved
Variant Requirements	Yes
Sponsors	Pfizer
Indications	chronic myeloid leukemia
Therapies	Bosutinib
Age Groups:	adult \| senior
Covered Countries	USA \| SWE \| NOR \| ITA \| FRA \| ESP \| DEU \| AUT